Nov 30, 2022 / 05:10PM GMT
Umer Raffat - Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity Research
Thank you, guys, for joining us. It's a pleasure to have Eli Lilly management join us. There's a lot to talk about.
But before we do, let me turn it over to Jake to kick things off.
Jacob S. Van Naarden - Eli Lilly and Company - Senior VP, CEO of Loxo Oncology & President of Lilly Oncology
Sure. I'm Jake Van Naarden, and I lead the oncology unit here at Lilly. And thanks to the Evercore ISI team for having us today. And maybe, David, you can just introduce yourself briefly as well.
David Hyman - Loxo Oncology, Inc. - Chief Medical Officer
David Hyman, medical oncologist by training and Chief Medical Officer for Oncology here at Loxo at Lilly.
Questions and Answers:
Umer Raffat - Evercore ISI Institutional Equities, Research Division - Senior MD & Senior Analyst of Equity ResearchExcellent, excellent, excellent. Well, just to